SFXN3 and oral cavity squamous cell carcinoma: Serum anti-SFXN3 levels in oral squamous cell carcinoma were slightly correlated with primary tumor size, and changes in serum anti-SFXN3 levels after treatment were correlated with clinical tumor load.